IBD patients face elevated lymphoma risk, study shows

A large population study confirms that people with inflammatory bowel disease have significantly higher rates of malignant lymphoma, a finding with major implications for treatment protocols and patient monitoring. The results could reshape how gastroenterologists manage IBD care and influence pharmaceutical development priorities for safer biologics.

Originaltitel: Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study